A.N. Galustyan

Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial

Leonardo R. Brandão, Matteo Luciani, Lisa Bomgaars et al. · The Lancet Haematology · 2020 · 134 citations · Full text

Thrombosis, Venous Disease, Venous Thrombosis +8

Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults

Yoseph Caraco, Gordon Crofoot, Pablo Andrés Moncada et al. · NEJM Evidence · 2021 · 96 citations

Health Sciences, Covid-19 Pandemic, Antiviral Drug Development +14

Meta-analysis of clinical trials of osteoarthritis treatment effectiveness with Chondroguard

I. Yu. Torshin, A. Yu. Kochish, A.N. Galustyan et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · 2021 · 50 citations · Full text

Pain Medicine, Non-operative Management, Orthopaedic Surgery +16

Analysis of 19.9 million publications from the PubMed/MEDLINE database using artificial intelligence methods: approaches to the generalizations of accumulated data and the phenomenon of “fake news

I. Yu. Torshin, L. V. Stakhovskaya, A.N. Galustyan et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · 2020 · 25 citations · Full text

Differences in the standardization of medicinal products based on extracts of chondroitin sulfate

I. Yu. Torshin, B. Ts. Zaychik, A. O. Ruzhitskiy et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · 2021 · 17 citations · Full text

Pharmaceutical Science, Nutraceutical Ingredient, Food Analysis +19